Rigel Pharmaceuticals is Drug Discovery in United States that focus on Rigel Pharmaceuticals Inc business. Founded in 1996. They cover business area such as Rigel Pharmaceuticals Inc, small-molecule drug, viral disease, AstraZeneca, overall responsibility, rigel royalty, milestone payment, its pipeline product, TAVALISSE (fostamatinib disodium hexahydrate) tablet, Fostamatinib, THF-beta Inhibitors.
1996
( 28 years old in 2024 )
Rigel Pharmaceuticals Inc
-
1180 Veterans Boulevard
South San Francisco, CA 94080
United States
Private
Rigel Pharmaceuticals Incsmall-molecule drugviral diseaseAstraZenecaoverall responsibilityrigel royaltymilestone paymentits pipeline productTAVALISSE (fostamatinib disodium hexahydrate) tabletFostamatinibTHF-beta Inhibitors
* We use standard office opening hours in near Rigel Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Rigel Pharmaceuticals is Drug Discovery business from United States that founded in 1996 (28 years old in 2024), Rigel Pharmaceuticals business is focusing on Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals headquarter office and corporate office address is located in 1180 Veterans Boulevard South San Francisco, CA 94080 United States.
Rigel Pharmaceuticals was founded in United States.
In 2024, Rigel Pharmaceuticals is currently focus on Rigel Pharmaceuticals Inc sector.
Above is snippet of Google Trends for "Rigel Pharmaceuticals Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Rigel Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
